President and COO of Celgene Corp. (CELG, Financial) Robert J Hugin sells 420,000 shares of CELG on 10/06/2009 at an average price of $53.55 a share.
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery development and commercialization of orally administered small molecule drugs for the treatment of cancer and immunological diseases. Celgene Corp. has a market cap of $24.78 billion; its shares were traded at around $54.04 with a P/E ratio of 37.5 and P/S ratio of 11.
CELG is in the portfolios of Lee Ainslie of Maverick Capital, David Swensen of Yale University, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, Kenneth Fisher of Fisher Asset Management, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Celgene Corp. by CEO:
Recent Trades of Celgene Corp. by Directors and Officers:
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery development and commercialization of orally administered small molecule drugs for the treatment of cancer and immunological diseases. Celgene Corp. has a market cap of $24.78 billion; its shares were traded at around $54.04 with a P/E ratio of 37.5 and P/S ratio of 11.
CELG is in the portfolios of Lee Ainslie of Maverick Capital, David Swensen of Yale University, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, Kenneth Fisher of Fisher Asset Management, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Celgene Corp. by CEO:
- Sell: CEO Sol J Barer sold 600,000 shares of CELG stock on 09/14/2009 at the average price of $52.12; the price of the stock has increased by 3.68% since.
Recent Trades of Celgene Corp. by Directors and Officers:
- Buy: Director James J Loughlin bought 600 shares of CELG stock on 05/06/2009 at the average price of $39.57; the price of the stock has increased by 36.57% since.
- Sell: Director Gilla Kaplan sold 40,000 shares of CELG stock on 09/04/2009 at the average price of $51.5; the price of the stock has increased by 4.93% since.
- Sell: Director Walter L Robb sold 37,500 shares of CELG stock on 07/27/2009 at the average price of $54.67; the price of the stock has decreased by 1.15% since.
- Sell: Director Walter L Robb sold 15,000 more shares of CELG stock on 05/29/2009 at the average price of $41.59; the price of the stock has increased by 29.94% since.
